Evidence map›Paper›PMID 35652963›Full record

ArticleEJNMMI research2022

Perspectives on translational molecular imaging and therapy: an overview of key questions to be addressed.

Fijs W B van Leeuwen, Margret Schottelius, Felix M Mottaghy, Fabien Hyafil, Mark Lubberink, Gabriela Kramer-Marek, Wim J G Oyen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fijs W B van LeeuwenInterventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands. F.w.b.van_leeuwen@lumc.nl.ORCID http://orcid.org/0000-0002-6844-4025
Margret SchotteliusUnit of Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Felix M MottaghyDepartment of Nuclear Medicine, University Hospital, RWTH Aachen University, Aachen, Germany.
Fabien HyafilDepartment of Nuclear Medicine, DMU IMAGINA, APHP, Hôpital Européen Georges-Pompidou, University of Paris, Paris, France.
Mark LubberinkRadiology and Molecular Imaging, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Gabriela Kramer-MarekDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
Wim J G OyenHumanitas Clinical and Research Center, Humanitas University, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35652963
PMCPMC9163234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.